The human body is comprised of trillions of cells. In the healthy case, human cells divide naturally in a controlled manner in order to replace cells as needed. The process in which the body's cells divide continually in an unregulated fashion and thereby spread into surrounding tissues is known as cancer. Since the entire body is made up of cells, it is possible for this condition to occur anywhere in the body. The chance of an individual having this condition is related to their genetics as well as other factors. These tumor cells being formed will eventually combine to form larger cellular masses or "tumors." These tumors are split into two main categories known as "malignant" and "benign." Benign tumors do not spread into nearby tissue ...
The overarching goal of this thesis is to establish a well-characterized platform to investigate the...
Purpose: The frst main aim of this study was to illustrate the absorbed dose rate distribution from ...
The dosage of a drug that doctors administer to cancer patients can be very dubious. In a real-world...
Radionuclide therapy using the small molecule PSMA bound to the beta-emitting radionuclide, Lutetium...
INTRODUCTION: While [(177)Lu]Lu-PSMA radioligand therapy is currently only applied in end-stage meta...
One promising treatment option for metastatic castration-resistant prostate cancer is systemic radio...
(Background) Aim of this retrospective analysis was to investigate in mCRPC patients treated with [1...
<bold>Introduction:</bold> Prostate specific membrane antigen (PSMA), highly expressed i...
Purpose: Internal dosimetry has become a very important tool to evaluate the risks and benefits of n...
IntroductionWe have previously shown that copper-64 (64Cu)-DOTHA2-PSMA can be used for positron emis...
Objectives: To utilize phosphorescence to monitor hypoxic microenvironment in solid-tumors and inves...
PURPOSE: [(177)Lu]Lu-PSMA-617 radioligand therapy ((177)Lu-PSMA) is a novel treatment for metastatic...
Purpose: [177Lu]Lu-PSMA-617 radioligand therapy (177Lu-PSMA) is a novel treatment for metastatic cas...
Purpose: To test the hypothesis that radiation-induced, transient G2/M arrest could potentially sens...
Imaging tumors and their response to treatment could be a valuable biomarker toward early assessment...
The overarching goal of this thesis is to establish a well-characterized platform to investigate the...
Purpose: The frst main aim of this study was to illustrate the absorbed dose rate distribution from ...
The dosage of a drug that doctors administer to cancer patients can be very dubious. In a real-world...
Radionuclide therapy using the small molecule PSMA bound to the beta-emitting radionuclide, Lutetium...
INTRODUCTION: While [(177)Lu]Lu-PSMA radioligand therapy is currently only applied in end-stage meta...
One promising treatment option for metastatic castration-resistant prostate cancer is systemic radio...
(Background) Aim of this retrospective analysis was to investigate in mCRPC patients treated with [1...
<bold>Introduction:</bold> Prostate specific membrane antigen (PSMA), highly expressed i...
Purpose: Internal dosimetry has become a very important tool to evaluate the risks and benefits of n...
IntroductionWe have previously shown that copper-64 (64Cu)-DOTHA2-PSMA can be used for positron emis...
Objectives: To utilize phosphorescence to monitor hypoxic microenvironment in solid-tumors and inves...
PURPOSE: [(177)Lu]Lu-PSMA-617 radioligand therapy ((177)Lu-PSMA) is a novel treatment for metastatic...
Purpose: [177Lu]Lu-PSMA-617 radioligand therapy (177Lu-PSMA) is a novel treatment for metastatic cas...
Purpose: To test the hypothesis that radiation-induced, transient G2/M arrest could potentially sens...
Imaging tumors and their response to treatment could be a valuable biomarker toward early assessment...
The overarching goal of this thesis is to establish a well-characterized platform to investigate the...
Purpose: The frst main aim of this study was to illustrate the absorbed dose rate distribution from ...
The dosage of a drug that doctors administer to cancer patients can be very dubious. In a real-world...